申请人:Asahi Kasei Kogyo Kabushiki Kaisha
公开号:US05658923A1
公开(公告)日:1997-08-19
An azepine compound of the formula ##STR1## wherein R is (a) ##STR2## in which R.sup.1 is hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen, or optionally substituted phenyl, and n is 0 or 1, (b) cycloalkyl of C.sub.5-8 which is optionally substituted by lower alkyl, (c) norbornyl, (d) bicyclo[3.3.1]nonyl, (e) naphthyl, (f) 1,3-benzoxolyl, (g) pyridyl, or (h) thienyl, m is an integer of 0-4, and C* is an asymmetric carbon, and nontoxic salts thereof, processes for producing the same, and therapeutic agents containing the same as the active ingredient for treating diseases related to .sigma.-receptor. The compound (1) and nontoxic salts thereof have a high affinity for .sigma.-receptor but scarcely any affinity for other receptors, thus being utilized for treating diseases related to .sigma.-receptor, such as schizophrenia.
一种azepine化合物,其化学式为##STR1##其中R为(a) ##STR2##其中R.sup.1为氢、较低烷基、较低烷氧基、羟基、卤素,或者可选择地取代苯基,n为0或1,(b) C.sub.5-8的环烷基,可选择地取代为较低烷基,(c) 诺邦基,(d) 双环[3.3.1]壬基,(e) 萘基,(f) 1,3-苯并噁唑基,(g) 吡啶基,或(h) 噻吩基,m为0-4的整数,C*为不对称碳,以及其无毒盐,制备该化合物的方法,以及包含该化合物作为活性成分的治疗剂,用于治疗与σ-受体相关的疾病。该化合物(1)及其无毒盐对σ-受体具有高亲和力,但几乎不与其他受体结合,因此可用于治疗与σ-受体相关的疾病,如精神分裂症。